• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ERIKA DE REYNOSA, S.A. DE C.V. STAY SAFE MTS SET; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ERIKA DE REYNOSA, S.A. DE C.V. STAY SAFE MTS SET; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Model Number 050-50758
Device Problem Fluid/Blood Leak (1250)
Patient Problems Abdominal Pain (1685); Peritonitis (2252)
Event Date 12/08/2021
Event Type  Injury  
Manufacturer Narrative
Clinical investigation: there is a temporal and possible casual relationship between the use of the stay safe mts set and the patient event of peritonitis.However, the set is not available to return for evaluation by the manufacturer and there are no photographs sent to show the leak.The patient had reported multiple leaks with two different lots.It is unknown which lot is related to the peritonitis event.The culture resulted positive for acinetobacter radioresistens which can be found in moist skin areas which could also suggest a possibility of a breach in aseptic technique occurred.Based on the available information, the exact cause of the patient¿s peritonitis cannot be determined.The stay safe mts set cannot be excluded as causing or contributing to the peritonitis event.The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.
 
Event Description
It was reported that a peritoneal dialysis (pd) patient was diagnosed with peritonitis.Upon follow up, the pd registered nurse (pdrn) reported the patient was seen in the pd clinic with complaints of abdominal pain.A pd effluent culture was obtained, and the patient was diagnosed with peritonitis.The patient was initiated on intraperitoneal (ip) antibiotics with vancomycin 2g and ceftazidime 2g.The patient continued with ip ceftazidime daily and received a second dose of vancomycin on (b)(6) 2021.The pd effluent culture resulted positive for acinetobacter radioresistens.The vancomycin was discontinued, and the patient has continued to take ceftazidime 2g daily.The cause of the patient¿s peritonitis event was attributed to the reported leak of the stay safe mts set.The patient was not hospitalized for this event and continues to complete treatment utilizing the liberty select cycler.
 
Manufacturer Narrative
Plant investigation: the sample was not returned to the manufacturer and the lot number was not provided.A manufacturing review was performed on the products shipped to the patient for the three (3) month time frame which immediately preceded the event occurrence date.This review included the lot numbers for all fresenius liberty stay safe mts sets shipped to this account within the selected time frame.The entire set of lots have been sold and distributed.There were no non-conformances or abnormalities identified during the manufacturing process which could be associated with the reported event.An investigation of the device history records (dhr) was conducted and confirmed that the results of the in-progress and final quality control (qc) testing met all requirements.The product lots involved met all specifications for release.A review of the dhr did not reveal a probable cause for the customer complaint.As a physical evaluation could not be performed, a definitive conclusion regarding the reported incident could not be reached and a cause could not be confirmed.
 
Event Description
It was reported that a peritoneal dialysis (pd) patient was diagnosed with peritonitis.Upon follow up, the pd registered nurse (pdrn) reported the patient was seen in the pd clinic with complaints of abdominal pain.A pd effluent culture was obtained, and the patient was diagnosed with peritonitis.The patient was initiated on intraperitoneal (ip) antibiotics with vancomycin 2g and ceftazidime 2g.The patient continued with ip ceftazidime daily and received a second dose of vancomycin on (b)(6) 2021.The pd effluent culture resulted positive for acinetobacter radioresistens.The vancomycin was discontinued, and the patient has continued to take ceftazidime 2g daily.The cause of the patient¿s peritonitis event was attributed to the reported leak of the stay safe mts set.The patient was not hospitalized for this event and continues to complete treatment utilizing the liberty select cycler.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STAY SAFE MTS SET
Type of Device
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
ERIKA DE REYNOSA, S.A. DE C.V.
mike allen #1331
parque industrial reynosa
reynosa 88780
MX  88780
Manufacturer (Section G)
ERIKA DE REYNOSA, S.A. DE C.V.
director, quality systems
1100 e, military hwy, suite c
pharr TX 78577
Manufacturer Contact
jason busch
920 winter st
waltham, MA 02451
9043166958
MDR Report Key13099959
MDR Text Key285174474
Report Number8030665-2021-01920
Device Sequence Number1
Product Code KDI
UDI-Device Identifier00840861100699
UDI-Public00840861100699
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K904806
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 01/12/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model Number050-50758
Device Catalogue Number050-50758
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Device AgeMO
Initial Date Manufacturer Received 12/21/2021
Initial Date FDA Received12/28/2021
Supplement Dates Manufacturer Received01/11/2022
Supplement Dates FDA Received01/12/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
DELFLEX PD FLUID; DELFLEX PD FLUID; LIBERTY CYCLER SET; LIBERTY CYCLER SET; LIBERTY SELECT CYCLER; LIBERTY SELECT CYCLER
Patient Outcome(s) Required Intervention;
Patient Age85 YR
Patient SexMale
-
-